These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11198060)

  • 1. Adverse effects associated with the use of donepezil in general practice in England.
    Dunn NR; Pearce GL; Shakir SA
    J Psychopharmacol; 2000; 14(4):406-8. PubMed ID: 11198060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Post-marketing observational study of donepezil].
    Ibach B
    Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820
    [No Abstract]   [Full Text] [Related]  

  • 3. Donepezil for Alzheimer's disease.
    Benjamin B; Burns A
    Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain injury, cognitive impairment, and donepezil.
    Whitlock JA
    J Head Trauma Rehabil; 1999 Aug; 14(4):424-7. PubMed ID: 10407214
    [No Abstract]   [Full Text] [Related]  

  • 5. Donepezil: a review.
    Seltzer B
    Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):527-36. PubMed ID: 16863459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of donepezil treatment on cardiovascular mortality.
    Sato K; Urbano R; Yu C; Yamasaki F; Sato T; Jordan J; Robertson D; Diedrich A
    Clin Pharmacol Ther; 2010 Sep; 88(3):335-8. PubMed ID: 20664535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [[Donepezil : a new option in the treatment of Alzheimer's disease] ONEPA].
    Azanza JR; Sádaba B; Quetglas EG; Escolar M
    Rev Med Univ Navarra; 1998; 42(2):109-18. PubMed ID: 10420948
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac safety of donepezil in elderly patients with Alzheimer disease.
    Isik AT; Yildiz GB; Bozoglu E; Yay A; Aydemir E
    Intern Med; 2012; 51(6):575-8. PubMed ID: 22449664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adverse events causing discontinuation of donepezil for Alzheimer's dementia].
    Carøe TK; Moe C
    Ugeskr Laeger; 2009 Dec; 171(50):3690-3. PubMed ID: 20003864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol abuse in an elderly woman taking donepezil for Alzheimer disease.
    Marinho V; Laks J; Engelhardt E; Conn D
    J Clin Psychopharmacol; 2006 Dec; 26(6):683-5. PubMed ID: 17110839
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical benefits of a new piperidine-class AChE inhibitor.
    Doody RS
    Eur Neuropsychopharmacol; 1999 Apr; 9 Suppl 2():S69-77. PubMed ID: 10332937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donepezil for Alzheimer's disease in clinical practice--The DONALD Study. A multicenter 24-week clinical trial in Germany.
    Froelich L; Gertz HJ; Heun R; Heuser I; Jendroska K; Kornhuber J; Kurz A; Mueller-Thomsen T; Ries F; Waechtler C; Metz M; Goebel C
    Dement Geriatr Cogn Disord; 2004; 18(1):37-43. PubMed ID: 15084792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donepezil-induced nightmares in mild cognitive impairment.
    Kitabayashi Y; Ueda H; Tsuchida H; Yamashita T; Narumoto J; Fukui K
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):123-4. PubMed ID: 16472374
    [No Abstract]   [Full Text] [Related]  

  • 14. [Galanthamine versus donepezil in the treatment of Alzheimer's disease].
    López-Pousa S; Garre-Olmo J; Vilalta-Franch J
    Rev Neurol; 2007 Jun 1-15; 44(11):677-84. PubMed ID: 17557224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An observational clinical study of the efficacy and tolerability of donepezil in the treatment of Alzheimer's disease.
    Hager K; Calabrese P; Frölich L; Göbel C; Berger FM
    Dement Geriatr Cogn Disord; 2003; 15(4):189-98. PubMed ID: 12626851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil.
    Suleyman T; Tevfik P; Abdulkadir G; Ozlem S
    Emerg Med J; 2006 Aug; 23(8):641-2. PubMed ID: 16858101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
    Black S; Román GC; Geldmacher DS; Salloway S; Hecker J; Burns A; Perdomo C; Kumar D; Pratt R;
    Stroke; 2003 Oct; 34(10):2323-30. PubMed ID: 12970516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 10-year perspective on donepezil.
    Cheewakriengkrai L; Gauthier S
    Expert Opin Pharmacother; 2013 Feb; 14(3):331-8. PubMed ID: 23316713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced lupus erythematosus associated with donepezil: a case report.
    Manzo C; Putignano S
    Age Ageing; 2015 Nov; 44(6):1062-3. PubMed ID: 26420637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.